LeddarTech Joins Baidu’s Apollo Autonomous Driving Open Platform

LeddarTech joins Baidu’s Apollo autonomous driving open platform with its LiDAR products through an open source SDK QUEBEC CITY, Jan. 08, 2019 (GLOBE NEWSWIRE) — LeddarTech, an industry leader providing the most versatile and scalable auto and mobility LiDAR platform, announced the integration of LeddarTech’s LiDAR products into Apollo, Baidu’s autonomous driving open platform. LeddarTech’s […]

Read More

Lupin Limited: Orphan Drug NaMuscla® Receives European Commission Approval for the Treatment of Myotonia in Non-Dystrophic Myotonic Disorders

Orphan Drug NaMuscla® Receives European Commission Approval for the Treatment of Myotonia in Non-Dystrophic Myotonic Disorders Zug, Switzerland, 8 January 2019: Lupin is pleased to announce that the European Commission (EC) has approved NaMuscla® (mexiletine) for the symptomatic treatment of myotonia in adults with non-dystrophic myotonic (NDM) disorders. Non-dystrophic myotonic disorders are a group of […]

Read More

Nanobiotix and MD Anderson Cancer Center announce a large-scale, comprehensive clinical collaboration on NBTXR3

Collaboration will initially support nine new phase I/II clinical trials with Nanobiotix’s first-in-class agent NBTXR3 for use in treating six cancer types – head and neck, pancreatic, thoracic, lung, gastrointestinal and genitourinary cancers – involving around 340 patients Most of the trials are expected to be launched in 2019 Collaboration includes a $12M total investment […]

Read More